Global Anticoagulant Market Trends and Forecasts 2017-2021

Report : Global Anticoagulant Market 2017-2021 is a new market research publication announced by Reportstack. 

Report Outline: Anticoagulant prevent clot formations or the enlargement of existing clots in the arteries or veins. Heparins, including unfractionated heparin (UFH) and low molecular weight heparin (LMWH); vitamin K antagonists; DTIs; and factor Xa inhibitors are among the anticoagulant that are available in the market. They are used for indications such as heart attack, stroke, deep venous thrombosis (DVT), pulmonary embolism (PE), surgery, angina, dialysis, atrial fibrillation (AF), thrombocytopenia, and myocardial infarction. Bayer HealthCare, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Johnson & Johnson, and Sanofi are some of the top vendors in the market.

For detailed report with TOC, please click here ​Global Anticoagulant Market 2017-2021

Market Growth: The global anticoagulant market to grow at a CAGR of 7.42% during the period 2017-2021.

Key vendors • Bayer HealthCare
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Daiichi Sankyo 
• Johnson & Johnson
• Sanofi

Other prominent vendors • Abbott Vascular
• Abiomed
• AtriCure
• Biosensors International
• Biotronik
• BioVentrix
• C. R. Bard

Regions Covered:

• Americas
• EMEA
• APAC

Companies Mentioned

Bayer HealthCare, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Johnson & Johnson, Sanofi, Abbott Vascular, Abiomed, AtriCure, Biosensors International, Biotronik, BioVentrix, C. R. Bard.

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###